Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease.
Roscioli T,
Cliffe ST,
Bloch DB,
Bell CG,
Mullan G,
Taylor PJ,
Sarris M,
Wang J,
Donald JA,
Kirk EP,
Ziegler JB,
Salzer U,
McDonald GB,
Wong M,
Lindeman R,
Buckley MF.
Centre for Vascular Research, University of New South Wales, Sydney 2052, Australia. tony.roscioli@email.cs.nsw.gov.au
We describe mutations in the PML nuclear body protein Sp110 in the syndrome veno-occlusive disease with immunodeficiency, an autosomal recessive disorder of severe hypogammaglobulinemia, combined T and B cell immunodeficiency, absent lymph node germinal centers, absent tissue plasma cells and hepatic veno-occlusive disease. This is the first report of the involvement of a nuclear body protein in a human primary immunodeficiency and of high-penetrance genetic mutations in hepatic veno-occlusive disease.
PMID: 16648851 [PubMed - indexed for MEDLINE]